| human | Q5 |
| P227 | GND ID | 1115677187 |
| P496 | ORCID iD | 0000-0001-6292-3087 |
| P214 | VIAF ID | 3208147665816760670003 |
| P10832 | WorldCat Entities ID | E39PBJhRJM9jRphmjGrVfb4THC |
| P69 | educated at | University of Toronto | Q180865 |
| McMaster University | Q632891 | ||
| P108 | employer | University of Toronto | Q180865 |
| Hospital for Sick Children | Q3140964 | ||
| P734 | family name | Wang | Q11573145 |
| Wang | Q11573145 | ||
| Wang | Q11573145 | ||
| P735 | given name | Xin | Q2867936 |
| Xin | Q2867936 | ||
| P106 | occupation | researcher | Q1650915 |
| Q39346476 | "miR miR on the wall, who's the most malignant medulloblastoma miR of them all?" |
| Q47851564 | ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas. |
| Q36631618 | Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. |
| Q57805008 | BMI1 is a therapeutic target in recurrent medulloblastoma |
| Q48698504 | Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells |
| Q33874592 | Characteristics and outcomes of Canadian MD/PhD program graduates: a cross-sectional survey. |
| Q37627692 | Cytogenetic prognostication within medulloblastoma subgroups |
| Q37073617 | Divergent clonal selection dominates medulloblastoma at recurrence |
| Q38194990 | Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent |
| Q38083798 | Emerging insights into the ependymoma epigenome |
| Q34240198 | Epigenomic alterations define lethal CIMP-positive ependymomas of infancy |
| Q55624498 | FORETINIB IS EFFECTIVE THERAPY FOR METASTATIC SONIC HEDGEHOG MEDULLOBLASTOMA. |
| Q38940977 | Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma. |
| Q38348188 | Fostering mentorship for clinician-investigator trainees: overview and recommendations. |
| Q39340576 | Here to stay: clinician investigator training in a changing environment |
| Q38120467 | Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma. |
| Q48554788 | It begins with the right supervisor: importance of mentorship and clinician-investigator trainee satisfaction levels in Canada |
| Q45984622 | MB-08FUNCTIONAL ROLES OF CCL2 IN MEDULLOBLASTOMA LEPTOMENINGEAL METASTASIS. |
| Q46354257 | MB-16NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL. |
| Q36493799 | Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? |
| Q35099027 | Medulloblastoma subgroups remain stable across primary and metastatic compartments |
| Q57295420 | Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma |
| Q45834929 | PTPS-08HEMATOGENOUS DISSEMINATION OF MEDULLOBLASTOMA METASTASES TO THE LEPTOMENINGES. |
| Q58617513 | Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma |
| Q48279284 | Scientific overview: CSCI - CITAC Annual General Meeting and Young Investigator's Forum 2012. |
| Q35218756 | Scientific overview: CSCI-CITAC Annual General Meeting and Young Investigator's Forum 2013. |
| Q48028072 | Scientific overview: CSCI-CITAC Annual General Meeting and Young Investigators' Forum 2014. |
| Q39521830 | Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells. |
| Q41969132 | Spatial heterogeneity in medulloblastoma |
| Q35958168 | Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype. |
| Q28271811 | Subgroup-specific structural variation across 1,000 medulloblastoma genomes |
| Q37316068 | TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma |
| Q38640971 | The Rising Challenge of Training Physician-Scientists: Recommendations From a Canadian National Consensus Conference. |
Search more.